The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Prostaglandins for preventing postpartum haemorrhage
Open accessAbstract
BACKGROUND: Prostaglandins have mainly been used for postpartum haemorrhage (PPH) when other measures fail. Misoprostol, a new and inexpensive prostaglandin E1 analogue, has been suggested as an alternative for routine management of the third stage of labour. OBJECTIVES: To assess the effects of prophylactic prostaglandin use in the third stage of labour. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (7 January 2011). We updated this search on 25 May 2012 and added the results to the awaiting classification section. SELECTION CRITERIA: Randomised trials comparing a prostaglandin agent with another uterotonic or no prophylactic uterotonic (nothing or placebo) as part of management of the third stage of labour. The primary outcomes were blood loss 1000 mL or more and the use of additional uterotonics. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed eligibility and trial quality and extracted data. MAIN RESULTS: We included 72 trials (52,678 women). Oral or sublingual misoprostol compared with placebo is effective in reducing severe PPH (oral: seven trials, 6225 women, not totalled due to significant heterogeneity; sublingual: risk ratio (RR) 0.66; 95% confidence interval (CI) 0.45 to 0.98; one trial, 661 women) and blood transfusion (oral: RR 0.31; 95% CI 0.10 to 0.94; four trials, 3519 women).Compared with conventional injectable uterotonics, oral misoprostol was associated with higher risk of severe PPH (RR 1.33; 95% CI 1.16 to 1.52; 17 trials, 29,797 women) and use of additional uterotonics, but with a trend to fewer blood transfusions (RR 0.84; 95% CI 0.66 to 1.06; 15 trials; 28,213 women). Additional uterotonic data were not totalled due to heterogeneity. Misoprostol use is associated with significant increases in shivering and a temperature of 38º Celsius compared with both placebo and other uterotonics. AUTHORS' CONCLUSIONS: Oral or sublingual misoprostol shows promising results when compared with placebo in reducing blood loss after delivery. The margin of benefit may be affected by whether other components of the management of the third stage of labour are used or not. As side-effects are dose-related, research should be directed towards establishing the lowest effective dose for routine use, and the optimal route of administration.Neither intramuscular prostaglandins nor misoprostol are preferable to conventional injectable uterotonics as part of the management of the third stage of labour especially for low-risk women; however, evidence has been building for the use of oral misoprostol to be effective and safe in areas with low access to facilities and skilled healthcare providers and future research on misoprostol use in the community should focus on implementation issues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Active versus expectant management in the third stage of labour
Prendiville, W. J., Elbourne, D., & McDonald, S. J. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000007 · Cited by 496
RetractedRETRACTED: Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage
Nasr, A. M., Shahin, A. Y., Elsamman, A. M., Zakherah, M. S., & Shaaban, O. M. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.01.018 · Cited by 45
RetractedBias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
WHO analysis of causes of maternal death: a systematic review
Khan, K. S., Wojdyla, D., Say, L., Gülmezoglu, A. M., & Van Look, P. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68397-9 · Cited by 3,978
Self-citationA modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints
Harbord, R. M., Egger, M., & Sterne, J. A. C. (2006) · Statistics in Medicine · doi:10.1002/sim.2380 · Cited by 2,267
Absorption kinetics of misoprostol with oral or vaginal administration
ZIEMAN, M., FONG, S., BENOWITZ, N., BANSKTER, D., & DARNEY, P. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00111-7 · Cited by 637
Active versus expectant management for women in the third stage of labour
Begley, C. M., Gyte, G. M., Devane, D., McGuire, W., & Weeks, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007412.pub4 · Cited by 446
WHO multicentre randomised trial of misoprostol in the management of the third stage of labour
Gülmezoglu, A. M., Villar, J., Ngoc, N. T. N., Piaggio, G., Carroli, G., Adetoro, L., Abdel-Aleem, H., Cheng, L., Hofmeyr, G. J., Lumbiganon, P., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05835-4 · Cited by 336
Self-citationDerman, R. J., Kodkany, B. S., Goudar, S. S., Geller, S. E., Naik, V. A., Bellad, M., Patted, S. S., Patel, A., Edlavitch, S. A., Hartwell, T., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69522-6 · Cited by 295
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
Westhoff, G., Cotter, A. M., & Tolosa, J. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001808.pub2 · Cited by 289
Prophylactic oxytocin for the third stage of labour
Cotter, A. M., Ness, A., & Tolosa, J. E. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001808 · Cited by 230
Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour
McDonald, S. J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000201.pub2 · Cited by 201
Active versus expectant management for women in the third stage of labour
Begley, C. M., Gyte, G. M., Devane, D., McGuire, W., & Weeks, A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007412.pub3 · Cited by 171
Walraven, G. E. L., Blum, J., Dampha, Y., Sowe, M., Morison, L. A., Winikoff, B., & Sloan, N. L. (2005) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00711.x · Cited by 145
Mobeen, N., Durocher, J. M., Zuberi, N. F., Jahan, N., Blum, J., Wasim, S., Walraven, G. E. L., & Hatcher, J. (2010) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02807.x · Cited by 136
H⊘j, L., Cardoso, P., Nielsen, B. B., Hvidman, L. E., Nielsen, J., & Aaby, P. (2005) · BMJ · doi:10.1136/bmj.331.7519.723 · Cited by 127
Prostaglandins for preventing postpartum haemorrhage
Gülmezoglu, A. M., Forna, F., Villar, J., & Hofmeyr, G. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000494.pub3 · Cited by 126
Self-citationHofmeyr, G. J., Gülmezoglu, A. M., Novikova, N., Linder, V., Ferreira, S. R. G., & Piaggio, G. G. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.08.055715 · Cited by 123
Self-citationMisoprostol dose‐related shivering and pyrexia in the third stage of labour
Lumbiganon, P., Hofmeyr, G. J., Gülmezoglu, A. M., Pinol, A., Villar, J., & Labour, F. T. W. C. T. O. M. I. T. M. O. T. T. S. O. (1999) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08266.x · Cited by 94
Self-citationProstaglandins for prevention of postpartum haemorrhage
Am, G., Forna, F., Villar, J., & Hofmeyr, G. J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000494 · Cited by 90
Self-citationPOESCHMANN, R. P., Doesburg, W. H., & Eskes, T. K. A. B. (1991) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1991.tb10364.x · Cited by 76
Prostaglandins for prevention of postpartum haemorrhage
Am, G., Forna, F., Villar, J., & Hofmeyr, G. J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000494.pub2 · Cited by 69
Self-citationSevere hyperthermia following oral misoprostol in the immediate postpartum period
Chong, Y. S., Chua, S., & ARULKUMARAN, S. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00275-5 · Cited by 53
Gibbens, D., Boyd, N. R. H., Crocker, S. G., Baumber, S., & Chard, T. (1972) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1972.tb14215.x · Cited by 45
Factors associated with acute postpartum hemorrhage in low-risk women delivering in rural India
GELLER, S. E., Goudar, S. S., Adams, M. G., Naik, V. A., Patel, A. A., Bellad, M. B., Patted, S. S., Edlavitch, S. A., Moss, N., Kodkany, B. S., et al. (2008) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2007.08.025 · Cited by 42
Patted, S. S., Goudar, S. S., Naik, V. A., Bellad, M. B., Edlavitch, S. A., Kodkany, B. S., Patel, A. A., Chakraborty, H., Derman, R. J., & GELLER, S. E. (2008) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050802452309 · Cited by 36
Fawcus, S., Mbizvo, M. T., Lindmark, G., & Nyström, L. (1995) · PubMed · Cited by 32
Miller, S., Tudor, C., Thorsten, V., Nyima, Kalyang, Sonam, S., Lhakpen, Droyoung, Quzong, K., Dekyi, T., et al. (2009) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2008.09.010 · Cited by 27
Murdoch, J., & Barnes, J. A. (1986) · doi:10.1007/978-1-349-09107-2_6 · Cited by 27
Elati, A., Elmahaishi, M., Elmahaishi, M., Elsraiti, O., & Weeks, A. D. (2010) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02821.x · Cited by 23
Clinical study on reduction of postpartum bleeding in cesarean section by misoprostol
Bi, L. (2005) · Zhongguo fuyou baojian · Cited by 13
Cited by
Renfrew, M. J., McFadden, A., Bastos, M. H., Campbell, J., Channon, A. A., Cheung, N. F., Silva, D. R. A. D., Downe, S., Kennedy, H. P., Malata, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60789-3 · Cited by 1,297
Prevention and Management of Postpartum Haemorrhage: Green‐top Guideline No. 52
(2017) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14178 · Cited by 756
Active versus expectant management for women in the third stage of labour
Begley, C. M., Gyte, G. M., Devane, D., McGuire, W., & Weeks, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007412.pub4 · Cited by 446
Treatment for primary postpartum haemorrhage
Mousa, H. A., Blum, J., Abou El Senoun, G., Shakur, H., & Alfirevic, Z. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003249.pub3 · Cited by 389
Sheldon, W., Blum, J., Vogel, J., Souza, J., Gülmezoglu, A., Winikoff, B., & on behalf of the WHO Multicountry Survey on Maternal and Newborn Health Research Network (2014) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12636 · Cited by 374
Self-citation
Metadata
- Authors
- Tunçalp, Ö., Hofmeyr, G. J., & Gülmezoglu, A. M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2012-08-15
- Volume
- 2012
- Issue
- 8
- Pages
- CD000494-CD000494
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1623889529
- Cited by
- 296
- References
- 32
- FWCI
- 21.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.